ArticleRegulatory toxicology and pharmacology : RTPPublished
Strategies to reduce the use of non-human primates in the development of oncology therapeutics: CD3-bispecifics
Regional connection
Verified Author affiliations on the Europe PMC record name Johnson & Johnson, Merck & Co. Affiliation source
- Institutions
- Johnson & Johnson, Merck & Co.
- County
- Montgomery County
Publication record
- Type
- Article
- Venue
- Regulatory toxicology and pharmacology : RTP
- Published
- Subject terms
- Animals; Primates; Humans; Neoplasms; Antineoplastic Agents; Antibodies, Bispecific; Drug Evaluation, Preclinical; CD3 Complex; Drug Development; Survey; Case Studies; Non-human Primate
- PubMed ID
- 40685066
- Added to directory
- Source checked